LINC01370

Across TCGA pan-cancer cohorts, LINC01370 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01370 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC01370 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01370 expression acts as an unfavorable survival marker, although some lineages such as LGG and BLCA show a favorable association.

THCA, KICH, and UCS are the cancer types where LINC01370 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.924	0.991	<.001	84	view →
KICH	OS	Tertile	All	0.161	0.881	<.001	72	view →
UCS	DFS	Tertile	All	0.140	0.476	.004	54	view →
LGG	DFS	Tertile	All	0.870	0.697	<.001	43	view →
THYM	DFS	Tertile	All	0.091	0.884	<.001	36	view →
UCEC	DFS	Tertile	IV	0.263	0.721	.011	36	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
SARC	DFS	Tertile	All	0.320	0.627	<.001	27	view →
ESCA	OS	Tertile	III,IV	0.428	0.611	.028	18	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
BLCA	DFS	Tertile	All	0.897	0.562	.028	18	view →
COAD	DFS	Tertile	All	0.201	0.696	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01370–THCA (OS)

Open the THCA breakdown →